Centro de Investigaciones y Proyectos en Neurociencias CIPNA

Barranquilla 080020

2 studies enrolling now · 10 studies all time

What they study most

Autism, Bipolar Depression, Bipolar I Depression, Chronic Schizophrenia, Depressive Disorder, Major, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Schizophrenia

Studies at this site

• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms — Recruiting now
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients — Recruiting now
• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant — Completed
• Pediatric Open-Label Extension Study — Completed
• Lurasidone Pediatric Bipolar Study — Completed
• A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310) — Completed
• Pediatric Schizophrenia Efficacy and Safety Study — Completed
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — Completed
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression — Completed